1-Bromo-4-(methoxymethoxy)benzene - CAS 25458-45-1
Catalog: |
BB018914 |
Product Name: |
1-Bromo-4-(methoxymethoxy)benzene |
CAS: |
25458-45-1 |
Synonyms: |
1-bromo-4-(methoxymethoxy)benzene; 1-bromo-4-(methoxymethoxy)benzene |
IUPAC Name: | 1-bromo-4-(methoxymethoxy)benzene |
Description: | 1-Bromo-4-(methoxymethoxy)benzene (CAS# 25458-45-1) is a useful research chemical. |
Molecular Weight: | 217.06 |
Molecular Formula: | C8H9BrO2 |
Canonical SMILES: | COCOC1=CC=C(C=C1)Br |
InChI: | InChI=1S/C8H9BrO2/c1-10-6-11-8-4-2-7(9)3-5-8/h2-5H,6H2,1H3 |
InChI Key: | BDRBSCRINVJXKW-UHFFFAOYSA-N |
Boiling Point: | 256.291 °C at 760 mmHg |
Density: | 1.423 g/cm3 |
LogP: | 2.43180 |
GHS Hazard Statement: | H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation] |
Precautionary Statement: | P261, P264, P271, P280, P302+P352, P304+P340, P305+P351+P338, P312, P321, P332+P313, P337+P313, P362, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
CN-108699013-A | Novel spiral quinone derivative compound, preparation method and contain its pharmaceutical composition as active constituent for preventing or treating neuropathy | 20160908 |
EP-3395804-A1 | Novel spiroquinone derivative compound, production method thereof, and pharmaceutical composition for preventing or treating neurological disorders which contains same as active ingredient | 20160908 |
EP-3395804-B1 | Novel spiroquinone derivative compound, production method thereof, and pharmaceutical composition for preventing or treating neurological disorders which contains same as active ingredient | 20160908 |
KR-101850062-B1 | Novel spiroquinone compound, method for preparing the same, and pharmaceutical composition for use in preventing or treating neurological diseases containing the same as an active ingredient | 20160908 |
KR-20180028391-A | Novel spiroquinone compound, method for preparing the same, and pharmaceutical composition for use in preventing or treating neurological diseases containing the same as an active ingredient | 20160908 |
Complexity: | 100 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 215.97859 |
Formal Charge: | 0 |
Heavy Atom Count: | 11 |
Hydrogen Bond Acceptor Count: | 2 |
Hydrogen Bond Donor Count: | 0 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 215.97859 |
Rotatable Bond Count: | 3 |
Topological Polar Surface Area: | 18.5 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 2.5 |
-
Catalog: BB044292
(+)-(8,8-Dichlorocamphorylsulfonyl)oxaziridine
Detail
-
Catalog: BB030539
(±)-2,3-Dibromobutane
Detail
-
Catalog: BB045655
((5-[(4-Chloro-3-methyl-1H-pyrazol-1-yl)methyl]-4-ethyl-4H-1,2,4-triazol-3-yl)thio)acetic acid
Detail
-
Catalog: BB030086
(1-Bromoethyl)benzene
Detail
-
Catalog: BB054256
((2S,4R)-2-((1H-1,2,4-Triazol-1-yl)methyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl)methanol
Detail
-
Catalog: BB025409
(1-Bromo-2,2,2-trifluoroethyl)benzene
Detail
-
Catalog: BB078021
(1-(3-Bromo-5-fluorophenyl)cyclopropyl)methanamine
Detail
-
Catalog: BB044157
(+)-2,10-(3,3-dichlorocamphorsultam)
Detail
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Halides
Customers Also Viewed
-
[6793-92-6]
4-Benzyloxybromobenzene
-
[84249-14-9]
2-Amino-4-bromopyridine
-
[99-14-9]
Tricarballylic acid
-
[1388152-02-0]
1,2-Cyclopentanediol, 3-amino-5-[(phosphonooxy)methy]-, ammonium salt (1:2), (1R,2S,3R,5R)-
-
[70684-84-3]
1-Boc-1,2,3,6-tetrahydropyridine-4-carboxylic Acid
-
[91-04-3]
2,6-Bis(hydroxymethyl)-p-cresol
INDUSTRY LEADERS TRUST OUR PRODUCTS